Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

(2018) Simeon U Springer et al.   eLife

Targeted sequencing of Plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations

(2018) Doreen N. Palsgrove et al.   HUMAN PATHOLOGY

Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder

(2017) Maria Del Carmen Rodriguez Pena et al.   VIRCHOWS ARCHIV

Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis

(2017) Zijie Wang et al.   Oncotarget

The Paris System for Reporting Urinary Cytology

(2016) Güliz A. Barkan et al.   ADVANCES IN ANATOMIC PATHOLOGY

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder

(2016) Morgan L. Cowan et al.   HUMAN PATHOLOGY

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

(2016) Doreen Nguyen et al.   VIRCHOWS ARCHIV

Epigenetic biomarkers in the blood of patients with urological malignancies

(2015) Jörg Ellinger et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

(2015) Faysal A. Yafi et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Low- and high-grade bladder cancer appraisal via serum-based proteomics approach

(2014) Navneeta Bansal et al.   CLINICA CHIMICA ACTA

Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies

(2014) Bernhard Ralla et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

(2013) I. Kinde et al.   CANCER RESEARCH

TERT promoter mutations in cancer development

(2013) Barbara Heidenreich et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Diagnostic terminology for urinary cytology reports including the new subcategories ‘atypical urothelial cells of undetermined significance’ (AUC-US) and ‘cannot exclude high grade’ (AUC-H)

(2013) E. Piaton et al.   CYTOPATHOLOGY

Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

(2013) Yves Allory et al.   EUROPEAN UROLOGY

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

(2013) Carolyn D. Hurst et al.   EUROPEAN UROLOGY

Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma

(2013) Glynis A Scott et al.   MODERN PATHOLOGY

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Johns Hopkins Hospital template for urologic cytology samples

(2012) Dorothy L. Rosenthal et al.   CANCER CYTOPATHOLOGY

FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing

(2012) Isaac Kinde et al.   PLoS One

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

(2011) George J. Netto   Nature Reviews Urology

Detection and quantification of rare mutations with massively parallel sequencing

(2011) I. Kinde et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events

(2010) Reza R. Serizawa et al.   INTERNATIONAL JOURNAL OF CANCER

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

(2010) Lucie C. Kompier et al.   PLoS One

9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology

(2009) Shigeto Kawauchi et al.   HUMAN PATHOLOGY

Bladder Cancer Detection Using FISH (UroVysion Assay)

(2008) Kevin C. Halling et al.   ADVANCES IN ANATOMIC PATHOLOGY